Tuesday, October 12th, 2010 - Raltitrexed (Tomudex®) in Combination With Cisplatin in the Treatment of MPM Improves Overall Survival Compared to Treatment With Cisplatin Alone
Archive for the 'Cisplatin (Platinol ®)' Category
Tuesday, June 26th, 2007 - Alimta®/Platinum-compound Combination Confirmed Active in Mesothelioma
Thursday, February 8th, 2007 - Chemo Combination Improves Survival in Asbestos-Related Cancer
Tuesday, May 23rd, 2006 - Lilly Oncology Prepares for Strong Showing at ASCO 2006; Targets Breast Cancer and Other Tumors with 79 Studies: 11 breast cancer studies; 29 thoracic cancer studies; and 8 studies with developing targeted agent
Monday, October 3rd, 2005 - Tomudex® Plus Platinol® Improves Survival of Patients with Malignant Pleural Mesothelioma
Thursday, September 22nd, 2005 - Mesothelioma Community Will Convene to Focus on Cure – International Research Symposium Unites Patients, Advocates, Foremost Medical Experts
Tuesday, July 5th, 2005 - Thoracic Cancer Patients Find New Reasons for Hope with Alimta®: New data may provide important treatment advances in mesothelioma and lung cancer
Thursday, February 24th, 2005 - Key ONCONASE ® Findings Presented at AACR Special Lung Cancer Conference: Findings discussed include ONCONASE’s enhancement of the efficacy of commonly used chemotherapeutic agents such as cisplatin and carboplatin
Monday, November 1st, 2004 - Alimta Approved as First Licensed Treatment for Mesothelioma, a Deadly Cancer Caused by Asbestos
Thursday, August 19th, 2004 - FDA Approves Lilly’s Alimta(R) (pemetrexed) for the Second-Line Treatment of Advanced Lung Cancer: Accelerated Approval Results in Second U.S. Indication in Six Months for Alimta
Tuesday, October 22nd, 2002 - Alimta Continues To Show Versatility in Treating Different Cancers
Tuesday, August 20th, 2002 - New Drug Nearly Doubles Survival Time For Mesothelioma Patients Pain, Other Symptoms Also Eased For Many
